Evidence map›Paper›PMID 42055814›Full record

ArticleThe Journal of international medical research2026

Malignant transformation in a patient with type 1 neurofibromatosis: A case report.

Shengjie Li, Wenshuo Hao, Yingming Xue

Abstract readCase Reports
In one paragraph

Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shengjie LiThe Department of Colorectal Surgery, University of Health and Rehabilitation Sciences, Qingdao Municipal Hospital, China.ORCID 0000-0003-0683-7349
Wenshuo HaoThe Department of Colorectal Surgery, University of Health and Rehabilitation Sciences, Qingdao Municipal Hospital, China.
Yingming XueThe Department of Colorectal Surgery, University of Health and Rehabilitation Sciences, Qingdao Municipal Hospital, China.ORCID 0000-0003-1129-5062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis is an autosomal dominant disease. The most common skin manifestation of type 1 neurofibromatosis is plexiform neurofibromas. Malignant peripheral nerve sheath tumors are rare and aggressive malignancies that predominantly arise from peripheral nerves and various nerve sheath cells. This report presents the case of a male patient in his late 50s who was diagnosed with malignant transformation of type 1 neurofibromatosis and treated surgically. The clinical manifestations, histopathological characteristics, treatment, and outcomes of this rare clinical case provide insights for subsequent diagnostic evaluation and clinical decision-making.

Indexed as

Cell Transformation, NeoplasticNerve Sheath NeoplasmsNeurofibroma, PlexiformNeurofibromatosis 1HumansMaleMiddle Agedmalignant peripheral nerve sheath tumormalignant transformationmitogen-activated protein kinaseNeurofibromatosisplexiform neurofibroma

Identifiers

PMID42055814
PMCPMC13150147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.